ClotProtect raises €670K Pre-Seed round
22 April 2024· Leeds, United Kingdom· health, defense, biotech, b2b, b2g, deep_hardware
To develop a molecule direct plasmin inhibitor intended to improve the treatment of severe bleeding by enhancing efficacy compared to existing treatments.
“Taking part in the Elevate Her Accelerator was a turning point for ClotProtect. The support, mentorship and belief from the Lifted team, particularly from Jordan, has been instrumental in helping us secure Innovate UK funding and close this £1.2m round. This investment gives us the platform to scale faster and bring our technology to more patients who need it.”
Investors
Leado2h Ventures
Also participating
Science Entrepreneur ClubUniversity of Leeds
About ClotProtect
Stage
Seed
Headquarters
Leeds, United Kingdom
Founded
2024
Team Size
6–20
Sectors
healthdefensebiotechb2bb2gdeep_hardware
Source: https://o2hventures.com/seis-investment-by-o2h-ventures-in-clotprotect-therapeutics/